New agents in cancer clinical trials

This publication has 54 references indexed in Scilit:

• Apicidin, an inhibitor of histone deacetylase, prevents H-ras-induced invasive phenotype
  Cancer Letters, 2000
• Antitumor Effects due to Irreversible Stoppage of Tumor Tissue Blood Flow: Evaluation of a Novel Combretastatin A-4 Derivative, AC7700
  Japanese Journal of Cancer Research, 1999
• A Novel Combretastatin A‐4 Derivative, AC‐7700, Shows Marked Antitumor Activity against Advanced Solid Tumors and Orthotopically Transplanted Tumors
  Japanese Journal of Cancer Research, 1999
• Exchange-rate policies in central Europe and monetary union
  Comparative Economic Studies, 1998
• PSYCH SELECTION
  Journal of Business Strategy, 1997
• DNA Sequence- and Structure-Selective Alkylation of Guanine N2 in the DNA Minor Groove by Ecteinascidin 743, a Potent Antitumor Compound from the Caribbean Tunicate Ecteinascidia turbinata
  Biochemistry, 1996
• Induction of Chronic Myelogenous Leukemia in Mice by the P210 ^bcr/abl Gene of the Philadelphia Chromosome
  Science, 1990
• Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4
  Cellular and Molecular Life Sciences, 1989
• The CML-Specific P210 bcr / abl Protein, Unlike v- abl , Does Not Transform NIH/3T3 Fibroblasts
  Science, 1987
• Programs Planned for the AAAS New York Meeting
  Science, 1960